Replies to post #154946 on Avid Bioservices Inc (CDMO)

[biopharm]

Sulaco, the FDA used the word "Immunotherapy" within the Fast Track Approval headlines and I was trying to find other Fast Track approvals but couldn't find one with "Immunotherapy" placed before the drugs name:

Peregrine Pharma Gets FDA Fast Track Designation For Immunotherapy Bavituximab

Peregrine Pharmaceuticals, Inc. ( PPHM ) said it has received Fast Track designation by the U.S. Food and Drug Administration or FDA for its lead investigational immunotherapy bavituximab for the potential treatment of second-line non-small cell lung cancer or NSCLC. The firm recently began a pivotal Phase III trial, SUNRISE, comparing bavituximab plus the chemotherapy docetaxel against placebo plus docetaxel in this indication.

http://www.nasdaq.com/article/peregrine-pharma-gets-fda-fast-track-designation-for-immunotherapy-bavituximab-20140106-00206

----------------------------------------------------------------

Maybe its just me, but it seems like Bavituximab is becoming more and more affiliated with "Cancer Immunotherapy" as its advancing. If Bavituximab does truly allow "a more robust immune response" in cancer treatment, its going to be one promising year in 2014 for all cancer patients.